Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer

International Journal of Cancer

Volumn 82, Issue 2, 1999, Pages 203-207

  Nindl, Ingo ^a   Rindfleisch, Knuth ^a   Lotz, Beatrix ^a   Schneider, Achim ^a   Dürst, Matthias ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS ONCOGENE; WART VIRUS;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, NEOPLASM; DNA, VIRAL; FEMALE; GERMANY; HUMANS; IMMUNOENZYME TECHNIQUES; MASS SCREENING; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; REPRESSOR PROTEINS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

EID: 0033052752     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990719)82:2<203::AID-IJC9>3.0.CO;2-9     Document Type: Article

References (27)

1. BONTKES, H.J. and 13 OTHERS, HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int. J. Cancer, 78, 166-171 (1998).
2. BOSCH, F.X., MANOS, M.M., MUÑOZ, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R. and SHAH, K.V., Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) study goup. J. nat. Cancer Inst., 87, 796-802 (1995).
3. CHAN, S.Y., BERNARD, H.U., ONG, C.K., CHAN, S.P., HOFMANN, B. and DELIUS, H., Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J. Virol., 66, 5714-5725 (1992).
4. CRUM, C.P. and Nuovo, G.J., The cervix. In: S. Sternberg (ed.), Diagnostic surgical pathology, pp. 2055-2090, Raven Press, New York (1994).
5. DE VILLIERS, E.M., Human pathogenic papillomavirus types: an update. Curr. Top. Microbiol. Immunol., 186, 1-12 (1994).
6. ESCHLE, D., DUERST, M., TER MEULEN, J., LUANDE, J., EBERHARDT, H.C., PAWLITA, M. and GISSMANN, L., Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J. gen. Virol., 73, 1829-1832 (1992).
7. FUJINAGA, Y., OKAZAWA, K., NISHIKAWA, A., YAMAKAWA, Y., FUKUSHIMA, M., KATO, I. and FUJINAGA, K., Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes, 9, 85-92 (1994).
8. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, 64, IARC, Lyon (1995).
9. ICENOGLE, J.P., SATHYA, P., MILLER, D.L., TUCKER, R.A. and RAWLS, W.E., Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology, 184, 101-107 (1991).
10. JACOBS, M.V., SNIJDERS, P.J., VAN DEN BRULE, A.J., HELMERHORST, T.J., MEIJER, C.L.J.M. and WALBOOMERS, J.M.M., A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. clin. Microbiol., 35, 791-795 (1997).
11. LONDESBOROUGH, P., HO, L., TERRY, G., CUZICK, J., WHEELER, C. and SINGER, A., Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer, 69, 364-368 (1996).
12. NEES, M., VAN WUNGAARDEN, E., BAKOS, E., SCHNEIDER, A. and DUERST, M., Identification of novel molecular markers which correlate with HPV-induced tumor progression. Oncogene, 16, 2447-2458 (1998).
13. NINDL, I., GREINKE, C., ZAHM, D.-M., STOCKFLETH, E., HOYER, H. and SCHNEIDER, A., Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR. Int. J. Gynecol. Pathol., 16, 197-204 (1997).
14. OSTOR, A.G., Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol., 12, 186-192 (1993).
15. REMMINK, A.J., WALBOOMERS, J.M.M., HELMERHORST, T.J., VOORHORST, F.J., ROZENDAAL, L., RISSE, E.K., MEIJER, C.L.J.M. and KENEMANS, P., The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer, 61, 306-311 (1995).
16. RICHART, R.M., Cervical intraepithelial neoplasia. Pathol. Ann., 8, 301-328 (1973).
17. RIOTTON, G., CHRISTOFFERSON, W.M. and LUNT, R., Cytology of the female genital tract. International histological classification of tumours, WHO, Geneva (1973).
18. SCHAFER, A., FRIEDMANN, W., MIELKE, M., SCHWARTLANDER, B. and KOCH, M.A., The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Amer. J. Obstet. Gynecol., 164, 593-599 (1991).
19. SEEDORF, K., KRAMMER, G., DUERST, M., SUHAI, S. and ROWEKAMP, W.G., Human papillomavirus type 16 DNA sequence. Virology, 145, 181-185 (1985).
20. SONG, Y.S., KEE, S.H., KIM, J.W., PARK, N.H., KANG, S.B., CHANG, W.H. and LEE, H.P., Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol. Oncol., 66, 275-281 (1997).
21. STOPPLER, M.C., CHING, K., STOPPLER, H., CLANCY, K., SCHLEGEL, R. and ICENOGLE, J., Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce P53 degradation. J. Virol., 70, 6987-6993 (1996).
22. VON KNEBEL DOEBERITZ, M., OLTERSDORF, T., SCHWARZ, E. and GISSMANN, L., Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res., 48, 3780-3786 (1988).
23. WANK, R. and THOMSSEN, C., High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature (Lond.), 352, 723-725 (1991).
24. YAMADA, T., MANOS, M.M., PETO, J., GREER, C.E., MUÑOZ, N., BOSCH, F.X. and WHEELER, C.M., Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol., 71, 2463-2472 (1997).
25. ZEHBE, I., VOGLINO, G., DELIUS, H., WILANDER, E. and TOMMASINO, M., Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet, 352, 1441-1442 (1998a).
26. ZEHBE, I., WILANDER, E., DELIUS, H. and TOMMASINO, M., Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res., 58, 829-833 (1998b).
27. ZUR HAUSEN, H., Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet, 343, 955-957 (1994).